Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
about
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.Diagnosis and initiation of treatment in Parkinson's disease.Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.Primary motor cortex LTP/LTD-like plasticity in probable corticobasal syndrome.Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression.
P2860
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
@en
type
label
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
@en
prefLabel
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
@en
P2093
P2860
P50
P356
P1433
P1476
Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts.
@en
P2093
Alice Rudolph
Gary Naglie
Ira Shoulson
Michael P McDermott
Parkinson Study Group DATATOP and PRECEPT investigators
Paula Rochon
P2860
P304
P356
10.1002/MDS.23581
P407
P577
2011-02-01T00:00:00Z